Reconsideration of the anemia management strategy for chronic kidney disease and dialysis patients
Abstract Anemia is common in patients with nondialysis-dependent (NDD) and dialysis-dependent (DD) chronic kidney disease (CKD). Although the capacity to produce substantial erythropoietin (EPO) remains high in these patients, insufficient EPO production is regarded as the main cause of renal anemia...
Saved in:
| Main Author: | Shoichiro Daimon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Renal Replacement Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41100-025-00612-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pre-dialysis and post-dialysis levels of serum potassium in patients with hemodialysis
by: HUANG Chun-hong, et al.
Published: (2020-01-01) -
Effect of peritoneal dialysis and hemodialysis dialysis on myocardial injury
by: NING Ya-xian, et al.
Published: (2017-01-01) -
Histochemical study of the skeletal muscle in children with chronic renal failure in dialysis treatment
by: LUCILA BIZARI FERNANDES DO PRADO, et al.
Published: (1998-09-01) -
Reversibility of chronic heart failure symptoms in chronic kidney disease patients
by: V. V. Belov, et al.
Published: (2007-02-01) -
The Efficacy and Safety of Roxadustat for Anemia in Hemodialysis Patients with Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials
by: Yunling Geng, et al.
Published: (2024-11-01)